L
Luis M. Ruilope
Researcher at European University of Madrid
Publications - 891
Citations - 109166
Luis M. Ruilope is an academic researcher from European University of Madrid. The author has contributed to research in topics: Blood pressure & Renal function. The author has an hindex of 94, co-authored 841 publications receiving 97778 citations. Previous affiliations of Luis M. Ruilope include Lund University & Mayo Clinic.
Papers
More filters
Journal ArticleDOI
Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting.
Paolo Palatini,Athanase Benetos,Guido Grassi,Stevo Julius,Sverre E. Kjeldsen,Giuseppe Mancia,K. Narkiewicz,Gianfranco Parati,Achille C. Pessina,Luis M. Ruilope,Alberto Zanchetti +10 more
TL;DR: The association between elevated resting heart rate and cardiovascular morbidity and mortality has been demonstrated in a large number of epidemiologic studies, but elevated heart rate is not yet considered to be a risk factor for cardiovascular disease.
Journal ArticleDOI
Serum Potassium and Clinical Outcomes in the Eplerenone Post–Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS)
TL;DR: Use of selective aldosterone blockade with eplerenone within the dose range of 25 to 50 mg/d in post–acute myocardial infarction patients with heart failure and left ventricular systolic dysfunction who are treated with standard therapy improves outcomes without an excess of risk of hyperkalemia.
Journal ArticleDOI
Blood Pressure Control and Physician Management of Hypertension in Hospital Hypertension Units in Spain
José R. Banegas,Julian Segura,Luis M. Ruilope,M. Luque,Rafael García-Robles,Carlos Campo,Fernando Rodríguez-Artalejo,Juan Tamargo +7 more
TL;DR: Control of BP, particularly of systolic BP, is still far from optimal in hospital-based hypertension units, and a more aggressive behavior of doctors treating uncontrolled hypertension is needed.
Journal ArticleDOI
A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism.
Hari K Parthasarathy,Joël Ménard,William B. White,William F. Young,Gordon H. Williams,Bryan Williams,Luis M. Ruilope,Gordon T. McInnes,John M. C. Connell,Thomas M. MacDonald +9 more
TL;DR: The antihypertensive effect of spironolactone was significantly greater than that of eplerenone in hypertension associated with primary aldosteronism.
Journal ArticleDOI
Renal function: the Cinderella of cardiovascular risk profile
TL;DR: Although there is no evidence-based information on the level of blood pressure that confers optimal renal protection, levels substantially lower than past recommendations are advisable and hypertensive kidney damage should be prevented by early treatment of hypertensive patients, particularly those with microalbuminuria.